- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Cardioplegia.
Displaying page 1 of 1.
EudraCT Number: 2017-005144-14 | Sponsor Protocol Number: 01-CARDIONIDO | Start Date*: 2018-04-12 |
Sponsor Name:Dr. Forteza Gil | ||
Full Title: Comparative study of two types of cardioplegia during cardiac surgery in the adult patient | ||
Medical condition: Cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015779-28 | Sponsor Protocol Number: | Start Date*: 2009-12-11 |
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | ||
Full Title: A single-centre randomised controlled trial of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients having isolated coronary artery bypass grafting (CABG) or ao... | ||
Medical condition: Myocardial injury after CABG or AVR surgery using cardiopulmonary bypass | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002701-59 | Sponsor Protocol Number: IIBSP-CAR-2018-71 | Start Date*: 2019-04-12 |
Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau | ||
Full Title: Randomized, open and multi-center clinical trial to compare the efficacy and safety of Buckberg vs Del Nido cardioplegia in isolated aortic valve replacement | ||
Medical condition: Myocardial protection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001923-22 | Sponsor Protocol Number: ADENOSINE-1 | Start Date*: 2015-12-16 |
Sponsor Name:Amphia Ziekenhuis | ||
Full Title: The effect of adenosine on myocardial protection in intermittent warm blood cardioplegia: a randomized placebo-controlled trial | ||
Medical condition: Post-operative cardiac damage in patients scheduled for minimal invasive, port-access operations | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006480-23 | Sponsor Protocol Number: 10,176 | Start Date*: 2007-10-12 |
Sponsor Name:University Hospitals of Leicester | ||
Full Title: Autologous Bone Marrow-Derived Cells for Cardioprotection During Heart Surgery | ||
Medical condition: Improvement of cardioprotection during elective coronary artery bypass graft surgery using the patients own bone marrow cells. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002643-10 | Sponsor Protocol Number: HCA-2011_1 | Start Date*: 2012-01-17 |
Sponsor Name:Heart Center Co. Tampere University Hospital | ||
Full Title: Intracoronary administration of levosimendan in cardiac surgery patients | ||
Medical condition: Dysfunction after opening of aortic cross-clamp in patients undergoing aortic valve and coronary artery bypass (AVR+CABG) operation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003776-40 | Sponsor Protocol Number: CL-N-CSM-AV-III/05/12 | Start Date*: 2013-11-08 |
Sponsor Name:Dr. Franz Köhler Chemie GmbH | ||
Full Title: A Prospective Randomized Double Blind Multicenter Phase III Study Comparing two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N versus Custodiol | ||
Medical condition: Patients with aortic valve disease and has to undergo aortic valve surgery +/- bypass surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003638-38 | Sponsor Protocol Number: FIM-SEV-2022-01 | Start Date*: 2023-04-10 | |||||||||||
Sponsor Name:FIMABIS | |||||||||||||
Full Title: CARDIOPROTECTIVE-NEPHROPROTECTIVE EFFECTS OF SEVOFLURAN IN COMPARISON WITH PROPOFOL IN DOUBLE VALVULAR SURGERY. USE OF SEVOFLURANE AS A PILLAR OF PROTECTION IN EXTRACORPOREA CIRCULATION AND POSTOPE... | |||||||||||||
Medical condition: DOBLE VALVE SURGERY | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020677-17 | Sponsor Protocol Number: ALMED-09-C3-026 | Start Date*: 2011-11-16 | |||||||||||
Sponsor Name:Air Liquide Santé International | |||||||||||||
Full Title: Efficacy and safety of xenon anaesthesia compared to sevoflurane anaesthesia and total intravenous anaesthesia for on-pump coronary artery bypass graft surgery: a randomised, three-arm, single-blin... | |||||||||||||
Medical condition: General anesthesia for on pump coronary artery bypass surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005992-81 | Sponsor Protocol Number: CL-N-CSM-III/01/08 | Start Date*: 2011-03-21 | |||||||||||
Sponsor Name:Dr. F. Köhler Chemie GmbH | |||||||||||||
Full Title: A Prospective Randomized Double Blind Multicenter Phase III Study Comparing two Methods of Cardioplegia in Coronary Artery Bypass Surgery Custodiol-N versus Custodiol | |||||||||||||
Medical condition: The study population will be selected from both genders with coronary artery disease (CAD) who are to undergo cardiopulmonary bypass for coronary artery bypass surgery. The ratio of incidence for b... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001382-26 | Sponsor Protocol Number: HCS-2014-2 | Start Date*: 2014-06-09 | ||||||||||||||||
Sponsor Name:TAYS Sydänsairaala | ||||||||||||||||||
Full Title: Adenosine in initial cardioplegia | ||||||||||||||||||
Medical condition: Coronary artery disease, aortic stenosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-001795-34 | Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20 | Start Date*: 2023-01-30 | |||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||
Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children | |||||||||||||
Medical condition: Preservation of hearts prior to heart transplantation in children | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004881-16 | Sponsor Protocol Number: P05633 | Start Date*: 2009-06-10 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | |||||||||||||
Full Title: The Effect of Acadesine on Clinically Significant Adverse Cardiovascular and Cerebrovascular Events in High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonar... | |||||||||||||
Medical condition: Coronary artery disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) ES (Prematurely Ended) DE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023552-90 | Sponsor Protocol Number: BQ123CPBP2010 | Start Date*: 2011-05-05 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Medizinische Universität Wien, Abteilung für Herzchirurgie | ||||||||||||||||||||||||||||||||||||||
Full Title: Short-term endothelin A receptor blockade in patients with on-pump coronary artery bypass grafting | ||||||||||||||||||||||||||||||||||||||
Medical condition: aorto-coronary bypass surgery in patients with coronary artery disease | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
